Mycobacterium Avium Complex (MAC)
Showing 1 - 25 of 5,949
Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto
Recruiting
- Nontuberculous Mycobacterial Lung Disease
- Nontuberculous Mycobacterium Infection
- Hypertonic saline
- +3 more
-
New York, New York
- +2 more
Jan 27, 2023
Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul
Not yet recruiting
- Mycobacterium Avium Complex Pulmonary Disease
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 7, 2023
Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)
Not yet recruiting
- Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
- Placebo
- +2 more
- (no location specified)
Aug 9, 2022
Pulmonary Mycobacterium Avium Complex Infection, Bronchiectasis, Lung Diseases Trial in United States (RHB-204, Placebo)
Recruiting
- Pulmonary Mycobacterium Avium Complex Infection
- +2 more
- RHB-204
- Placebo
-
Glendale, California
- +24 more
Jan 23, 2023
Drug Exposure and Minimum Inhibitory Concentration in Treatment
Not yet recruiting
- Mycobacterium Avium Complex
- +3 more
- Drug exposure
-
Shanghai, ChinaShanghai Pulmonary Hospital
Apr 10, 2023
Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease Trial in United States (SPR720, Placebo, Open-label
Terminated
- Mycobacterium Avium Complex
- Non-tuberculous Mycobacterium Pulmonary Disease
- SPR720
- +2 more
-
Altamonte Springs, Florida
- +8 more
Feb 3, 2022
Lung Infection, Mycobacterium Avium Complex Trial in Amiens, Marseille (Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin)
Recruiting
- Lung Infection
- Mycobacterium Avium Complex
- Clarithromycin 1000 MG
- +3 more
-
Amiens, Picardie, France
- +1 more
Aug 23, 2021
Energy Metabolism for the Pulmonary Mycobacterium Avium Complex
Completed
- Pulmonary MAC
- +2 more
-
Joyo, Kyoto, JapanNational Hospital Organization Minami Kyoto Hospital
Dec 26, 2021
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)
Recruiting
- Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
- Bedaquiline
- +4 more
-
Aichi, Japan
- +42 more
Jan 17, 2023
Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of
Completed
- Mycobacterium Avium-intracellulare Infection
- +2 more
-
San Francisco, California
- +14 more
Oct 27, 2021
Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)
Not yet recruiting
- Mycobacterium Avium Complex Pulmonary Disease
- (no location specified)
May 15, 2023
Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Indinavir sulfate, Ritonavir, Ethambutol
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Indinavir sulfate
- +4 more
-
Birmingham, Alabama
- +33 more
Oct 28, 2021
Mycobacterium Avium-intracellulare Infection, HIV Trial in Tanzania, United States (Clarithromycin, Rifabutin)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
-
Birmingham, Alabama
- +41 more
Oct 28, 2021
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Ethambutol HCl, Clarithromycin, Clofazimine)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Ethambutol hydrochloride
- +3 more
-
San Francisco, California
- +15 more
Oct 28, 2021
Mycobacterium Avium Complex Trial in Baltimore (Azithromycin)
Recruiting
- Mycobacterium Avium Complex
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Mar 7, 2022
MAC Lung Disease Trial in United States (Epetraborole, Placebo)
Recruiting
- MAC Lung Disease
- Treatment Refractory MAC Lung Disease
- Epetraborole
- Placebo
-
Birmingham, Alabama
- +40 more
Jan 31, 2023
Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,
Recruiting
- Mycobacterium Avium Complex
- Nontuberculous Mycobacterium Infection
- Azithromycin
- +2 more
-
Loma Linda, California
- +26 more
Jan 18, 2023
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Azithromycin)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
-
San Francisco, California
- +18 more
Oct 27, 2021
Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)
Completed
- Mycobacterium Infections, Nontuberculous
- LAI (Liposomal Amikacin for Inhalation) 590 mg
- (no location specified)
Apr 22, 2020
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Active, not recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +110 more
Jan 23, 2023
Mycobacterium Avium-intracellulare Infection, HIV Trial in United States (Nelfinavir mesylate, Nevirapine, Azithromycin)
Completed
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
- Nelfinavir mesylate
- +2 more
-
Birmingham, Alabama
- +25 more
Oct 27, 2021
HIV Infection, HIV-1 Infection, Mycobacterium Avium Complex (MAC) Trial in Ottawa (Rifabutin, Maraviroc)
Completed
- HIV Infection
- +2 more
-
Ottawa, Ontario, CanadaThe Ottawa Hospital -General Campus
Feb 25, 2020
NTM Lung Infection Due to MAC Trial (LAI 590 mg, Multi-drug regimen)
Completed
- NTM Lung Infection Due to MAC
- LAI 590 mg
- Multi-drug regimen
- (no location specified)
Jan 21, 2020
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023